The latest leukaemia news
New function discovered for protein important in leukaemia
Researchers from Northwestern University, USA, have stumbled upon a previously unobserved function of a protein…
Browsing: Leukaemia
New test predicts immune effector cell-associated neurotoxicity syndrome
Medical researchers in Japan have discovered a way to predict immune effector cell-associated neurotoxicity syndrome,…
The US Leukemia & Lymphoma society denounces government actions that threaten cancer patients
Statement from the US Leukemia & Lymphoma Society As the nation’s largest organisation serving the…
EC approval for blinatumomab in Philadelphia chromosome-negative CD19-positive B-cell precursor acute lymphoblastic leukaemia in the consolidation phase
The European Commission (EC) has approved blinatumomab monotherapy as consolidation therapy for treating adult patients…
Investigators pinpoint keys to cell therapy response for leukaemia
Dana-Farber Cancer Institute researchers (USA) have identified factors that determine whether donor lymphocyte infusion (DLI),…
New guidelines for managing blood cancers in pregnancy
A new set of guidelines has been developed to assist with the diagnosis and expert…
Immunotherapy against cancer: How therapeutic antibodies do their job
In blood cancers such as chronic lymphocytic leukemia, B cells of the immune system multiply…
New findings could lead to better treatment for blood cancer
Which medicine is best when you are affected by cancer? This can vary from person to…
ASH 2024: Preclinical study shows targeted drug strengthens the power of CAR T-cell therapy in two paediatric leukaemias
A preclinical study led by a faculty member at Roswell Park Comprehensive Cancer Center shows…
ASH 2024: Combination of two oral agents improves progression-free survival in previously untreated chronic lymphocytic leukaemia
Among patients with previously untreated chronic lymphocytic leukemia (CLL), those who received a combination regimen…